In the past few years, there appears to have been a change in the spectrum of disease caused by group A ,-haemolytic streptococcus (GABHS), and a toxic shock-like syndrome caused by this organism has recently been described in adults. We report four children with an acute illness characterised by rapid progression of shock, erythematous rash, multisystem organ involvement, electrolyte derangements, and desquamation who fulfil the previously established diagnostic criteria for toxic shock syndrome. Three of the children had extensive cutaneous and soft tissue infection and the fourth had peritonitis. All four developed bacteraemia. Treatment included aggressive cardiovascular resuscitation and antibiotic therapy. Although no patient died, they suffered multiple and severe complications requiring prolonged treatment and hospitalisation. Streptococcal toxic shock syndrome is a separate and clearly defined entity occurring in previously healthy children.
In 1978, Todd and Fishaut described seven children with an acute disease characterised by fever, mucous membrane hyperaemia, subcutaneous oedema, desquamating erythroderma and rapid progression to hypotension and multisystem organ involvement, and which they called staphylococcal toxic shock syndrome. ' The disorder subsequently became more widely recognised as an illness affecting young women, which was associated with vaginal colonisation by Staphylococcus aureus and the use of tampons. At least 13% ofcases are not associated with menstruation but with focal staphylococcal infections and/or colonisation,3 and a significant proportion of these non-menstrual cases are children.
In the past decade, major advances have occurred in the understanding of the pathogenesis of staphylococcal toxic shock syndrome. It is now well established that most cases are caused by a number of related enterotoxins produced by S aureus, the most common of which is the 22 kDa protein called toxic shock syndrome toxin-I (TSST-1). TSST-1 and other enterotoxins are thought to cause the disorder by activating host inflammatory responses, and in particular by triggering release of cytokines."
In the past four years, there have been a number of reports of a toxic shock-like disorder occurring in both adults and children, which has been associated not with S aureus but with group A j3-haemolytic streptococcus (GABHS). 73 Furthermore, there appears to have been an increase in the prevalence of serious invasive disease due to GABHS in many parts of the world. 126
In order to illustrate the clinical and pathological features of the disease, we report four children with streptococcus associated toxic shock syndrome and discuss the mechanisms involved in its pathogenesis. Swelling of the soft tissues over her right wrist and elbow joints became more noticeable. As she was weaned off muscle relaxant drugs, a compartment compression syndrome was diagnosed in her right forearm and in both legs. Fasciotomy was carried out in all affected limbs and yellow fluid drained from the fasciae. In spite of the decompression of her forearm, the muscles looked progressively less viable over the next few days. A bone scan suggested an avascular right ulna. Antibiotic therapy was changed to cefotaxime and clindamycin. Sensation of the right hand disappeared, and three weeks after admission, amputation of the right upper limb below the elbow was carried out. Additional amputation of her feet was avoided, although extensive skin grafting was necessary. Progressive clinical recovery followed with re-establishment of normal renal, hepatic, and pulmonary function. She returned to the local hospital five weeks after initial admission. On follow up one and four months later she was found to be asymptomatic and thriving. Case 4 Pallor and hypothermia developed in a 10 week old girl. Over the next 18 hours a small red lesion in the left submandibular region became indurated, swollen, and hot, and extended to involve both sides of her neck. On admission to the Hospital for Sick Children she was febrile (39-5°C), her blood pressure was 75/35 mmHg, heart rate 200 beats/min, and respiratory rate 65/min. The oral mucosae were reddened and she was very poorly perfused. She was resuscitated with plasma and crystalloids, requiring 350 ml/kg in the first day. In addition, she was started on flucloxacillin, gentamicin, and ampicillin. Two hours after admission she developed metabolic acidosis, bradycardia, and apnoea, requiring mechanical ventilation. On her initial investigations she was found to have a haemoglobin concentration of 80 g/l, sodium 123 mmol/l, potassium 2-4 mmol/l, chloride 93 mmol/l, calcium 1-9 mmol/l, high of creatine phosphokinase at 826 U/1, and prolonged coagulation tests. Two right sided focal seizures were observed in the first 6 hours. Cerebrospinal fluid examination was normal. Blood cultures grew GABHS, and penicillin plus gentamicin were continued. Within the first two days, she developed progressive anaemia (lowest haemoglobin 70 g/l) requiring packed red blood cells, and a generalised erythematous rash which later desquamated. Over the next 48 hours, her shock resolved but she continued to require ventilation. Mechanical ventilation was stopped after three days. The cellulitis subsided slowly and the patient was discharged on oral antibiotics on day 14.
Discussion
The four children reported in this series all suffered from a fulminant disorder characterised by shock, multisystem involvement, and a distinctive erythematous rash, which fulfilled the diagnostic criteria for toxic shock syndrome, but was associated not with staphylococcal infection but with GABHS sepsis. These cases are strikingly similar to the reports of streptococcal toxic shock syndrome in adults,7-11 and to a similar disorder previously described after varicella infection in three children.'2 13 The clinical and laboratory features in these cases are sufficiently distinctive and dramatic that they could hardly have gone unrecognised by clinicians in the past few decades. The question therefore arises as to whether the growing number of reports of streptococcal toxic shock syndrome represents the emergence of a 'new' streptococcus associated syndrome, or whether it reflects the rediscovery of an entity which may have been more common in the preantibiotic era.
Before 1940, streptococcal infections accounted for a major proportion of infectious conditions seen in many centres in developed countries. Deaths from streptococcal bacteraemia, severe scarlet fever, and erysipelas were common.'0 21 The fatality rate for streptococcal bacteraemia was found to be 72% in the total population and 62% in children under 15 
